The model is successfully fit to simulated data with an underlying nature which is unambiguously diffusive, as opposed to DNS data where the underlying nature is in question.
The admissibility of these data is similarly in question, with data provenance front-and-center.
That could be a boost for defense teams, but a potential setback for individual users whose data may be in question.
Nevertheless, the analysis of this data is not without question, especially in the absence of the genome sequence.
The sustainability of CVI data collection and analysis has also been in question since 2007.
Although statistically significant differences in GAPDH pool level were seen at several time points in both age groups, a confounding variable in the data was the question of protein degradation in the ischemic muscle as related to the I/R injury.
Here is some of the prominent research whose data was questioned in recent years: And those are just a few prominent cases in top academic journals.
This requires them to infer what the value of such data is for the business in question through data analysis as well as acting promptly for critical or relevant situations.
Replication or lack of replication of gene-disease association data is a central open question in this type of research.
Frequently, the combination of quantitative and qualitative data is used when the phenomena in question are complex and require in-depth study of many aspects [ 41].
